HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 20-DEC-21 5SCR TITLE CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM MYCOBACTERIUM TITLE 2 TUBERCULOSIS BOUND TO NADP AND SDDC INHIBITOR SDDC-735 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MTDHFR; COMPND 5 EC: 1.5.1.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS H37RV; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: ATCC 25618 / H37RV; SOURCE 5 GENE: FOLA, DFRA, RV2763C, MTV002.28C; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS MYCOBACTERIUM TUBERCULOSIS, DHFR, NADP, FOLATE, OXIDOREDUCTASE- KEYWDS 2 OXIDOREDUCTASE INHIBITOR COMPLEX, STRUCTURAL GENOMICS, SEATTLE KEYWDS 3 STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE, SSGCID EXPDTA X-RAY DIFFRACTION AUTHOR SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE (SSGCID) REVDAT 2 02-MAR-22 5SCR 1 KEYWDS REVDAT 1 09-FEB-22 5SCR 0 JRNL AUTH S.J.MAYCLIN,J.W.FAIRMAN,D.M.DRANOW,D.G.CONRADY,D.FOX III, JRNL AUTH 2 C.M.LUKACS,D.D.LORIMER,P.S.HORANYI,T.E.EDWARDS,J.ABENDROTH JRNL TITL CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM JRNL TITL 2 MYCOBACTERIUM TUBERCULOSIS BOUND TO NADP AND SDDC INHIBITOR JRNL TITL 3 SDDC-735 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.98 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 12061 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 603 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.9816 - 3.0948 1.00 3018 159 0.1489 0.1794 REMARK 3 2 3.0948 - 2.4566 1.00 2872 152 0.1866 0.2432 REMARK 3 3 2.4566 - 2.1462 1.00 2843 150 0.1804 0.2511 REMARK 3 4 2.1462 - 1.9500 0.96 2725 142 0.1884 0.2591 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.570 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.87 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1423 REMARK 3 ANGLE : 0.947 1951 REMARK 3 CHIRALITY : 0.056 204 REMARK 3 PLANARITY : 0.004 248 REMARK 3 DIHEDRAL : 18.973 801 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID -6 THROUGH 24 ) REMARK 3 ORIGIN FOR THE GROUP (A): -9.5456 -4.3300 14.5807 REMARK 3 T TENSOR REMARK 3 T11: 0.0511 T22: 0.1222 REMARK 3 T33: 0.1068 T12: -0.0005 REMARK 3 T13: -0.0111 T23: -0.0041 REMARK 3 L TENSOR REMARK 3 L11: 1.6441 L22: 2.7813 REMARK 3 L33: 2.6842 L12: 0.0320 REMARK 3 L13: -0.1542 L23: 1.3394 REMARK 3 S TENSOR REMARK 3 S11: 0.0866 S12: -0.0622 S13: -0.0400 REMARK 3 S21: -0.0206 S22: -0.0647 S23: -0.1167 REMARK 3 S31: -0.0411 S32: 0.0026 S33: -0.0574 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 25 THROUGH 60 ) REMARK 3 ORIGIN FOR THE GROUP (A): -1.7383 -0.4095 9.5950 REMARK 3 T TENSOR REMARK 3 T11: 0.0553 T22: 0.1810 REMARK 3 T33: 0.1113 T12: -0.0005 REMARK 3 T13: 0.0056 T23: -0.0140 REMARK 3 L TENSOR REMARK 3 L11: 2.6595 L22: 2.2399 REMARK 3 L33: 1.8796 L12: -0.7855 REMARK 3 L13: 0.5243 L23: -0.4832 REMARK 3 S TENSOR REMARK 3 S11: 0.0470 S12: -0.0277 S13: 0.0013 REMARK 3 S21: 0.0169 S22: 0.0072 S23: -0.1104 REMARK 3 S31: -0.0932 S32: 0.2039 S33: -0.0556 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 61 THROUGH 159 ) REMARK 3 ORIGIN FOR THE GROUP (A): -11.8281 -4.5243 12.8674 REMARK 3 T TENSOR REMARK 3 T11: 0.0781 T22: 0.1133 REMARK 3 T33: 0.1006 T12: 0.0048 REMARK 3 T13: 0.0148 T23: -0.0237 REMARK 3 L TENSOR REMARK 3 L11: 1.3679 L22: 0.9191 REMARK 3 L33: 2.0925 L12: 0.1178 REMARK 3 L13: 0.7558 L23: -0.2061 REMARK 3 S TENSOR REMARK 3 S11: 0.0682 S12: -0.0497 S13: 0.0298 REMARK 3 S21: 0.0522 S22: -0.0222 S23: 0.0488 REMARK 3 S31: -0.0101 S32: -0.0408 S33: -0.0600 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5SCR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JAN-22. REMARK 100 THE DEPOSITION ID IS D_1001404344. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING COPPER ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : FRE+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12061 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.37300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: WIZARD 3/4 B6: 20% PEG 6000, 100MM REMARK 280 CITRIC ACID/ NAOH PH4.0, 100MM LICL; R9978 AT 39.8MG/ML W/ REMARK 280 3.75MM EBSI5524 AMD 10MM NADP, TRAY 266660B6; PUCK KQT0-14; CRYO REMARK 280 25% EG, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 14.95500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.32500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.74000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.32500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 14.95500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.74000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS A MONOMER, THE SAME AS ASU REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A -6 CG CD1 CD2 REMARK 470 VAL A -5 CG1 CG2 REMARK 470 LYS A 53 CG CD CE NZ REMARK 470 ARG A 143 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 398 O HOH A 418 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 21 31.50 -80.71 REMARK 500 REMARK 500 REMARK: NULL DBREF 5SCR A 1 159 UNP P9WNX1 DYR_MYCTU 3 161 SEQADV 5SCR MET A -19 UNP P9WNX1 INITIATING METHIONINE SEQADV 5SCR GLY A -18 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR SER A -17 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR SER A -16 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR HIS A -15 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR HIS A -14 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR HIS A -13 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR HIS A -12 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR HIS A -11 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR HIS A -10 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR SER A -9 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR SER A -8 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR GLY A -7 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR LEU A -6 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR VAL A -5 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR PRO A -4 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR ARG A -3 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR GLY A -2 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR SER A -1 UNP P9WNX1 EXPRESSION TAG SEQADV 5SCR HIS A 0 UNP P9WNX1 EXPRESSION TAG SEQRES 1 A 179 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 179 LEU VAL PRO ARG GLY SER HIS MET VAL GLY LEU ILE TRP SEQRES 3 A 179 ALA GLN ALA THR SER GLY VAL ILE GLY ARG GLY GLY ASP SEQRES 4 A 179 ILE PRO TRP ARG LEU PRO GLU ASP GLN ALA HIS PHE ARG SEQRES 5 A 179 GLU ILE THR MET GLY HIS THR ILE VAL MET GLY ARG ARG SEQRES 6 A 179 THR TRP ASP SER LEU PRO ALA LYS VAL ARG PRO LEU PRO SEQRES 7 A 179 GLY ARG ARG ASN VAL VAL LEU SER ARG GLN ALA ASP PHE SEQRES 8 A 179 MET ALA SER GLY ALA GLU VAL VAL GLY SER LEU GLU GLU SEQRES 9 A 179 ALA LEU THR SER PRO GLU THR TRP VAL ILE GLY GLY GLY SEQRES 10 A 179 GLN VAL TYR ALA LEU ALA LEU PRO TYR ALA THR ARG CYS SEQRES 11 A 179 GLU VAL THR GLU VAL ASP ILE GLY LEU PRO ARG GLU ALA SEQRES 12 A 179 GLY ASP ALA LEU ALA PRO VAL LEU ASP GLU THR TRP ARG SEQRES 13 A 179 GLY GLU THR GLY GLU TRP ARG PHE SER ARG SER GLY LEU SEQRES 14 A 179 ARG TYR ARG LEU TYR SER TYR HIS ARG SER HET NAP A 201 48 HET GXJ A 202 27 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM GXJ (2R)-3-(2-{3-[(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL) HETNAM 2 GXJ OXY]PROPOXY}PHENYL)-2-METHYLPROPANOIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 GXJ C19 H26 N4 O4 FORMUL 4 HOH *128(H2 O) HELIX 1 AA1 LEU A 24 MET A 36 1 13 HELIX 2 AA2 ARG A 44 LEU A 50 1 7 HELIX 3 AA3 SER A 81 ALA A 85 5 5 HELIX 4 AA4 GLY A 96 LEU A 104 1 9 HELIX 5 AA5 PRO A 105 ALA A 107 5 3 SHEET 1 AA1 8 GLU A 77 VAL A 79 0 SHEET 2 AA1 8 ARG A 61 LEU A 65 1 N VAL A 64 O GLU A 77 SHEET 3 AA1 8 THR A 39 GLY A 43 1 N ILE A 40 O ARG A 61 SHEET 4 AA1 8 GLU A 90 VAL A 93 1 O TRP A 92 N THR A 39 SHEET 5 AA1 8 MET A 1 ALA A 9 1 N MET A 1 O THR A 91 SHEET 6 AA1 8 ARG A 109 VAL A 115 1 O THR A 113 N GLN A 8 SHEET 7 AA1 8 ARG A 150 HIS A 157 -1 O TYR A 154 N VAL A 112 SHEET 8 AA1 8 ARG A 136 THR A 139 -1 N ARG A 136 O HIS A 157 SHEET 1 AA2 8 GLU A 77 VAL A 79 0 SHEET 2 AA2 8 ARG A 61 LEU A 65 1 N VAL A 64 O GLU A 77 SHEET 3 AA2 8 THR A 39 GLY A 43 1 N ILE A 40 O ARG A 61 SHEET 4 AA2 8 GLU A 90 VAL A 93 1 O TRP A 92 N THR A 39 SHEET 5 AA2 8 MET A 1 ALA A 9 1 N MET A 1 O THR A 91 SHEET 6 AA2 8 ARG A 109 VAL A 115 1 O THR A 113 N GLN A 8 SHEET 7 AA2 8 ARG A 150 HIS A 157 -1 O TYR A 154 N VAL A 112 SHEET 8 AA2 8 ARG A 143 PHE A 144 -1 N ARG A 143 O TYR A 151 SHEET 1 AA3 2 VAL A 13 GLY A 15 0 SHEET 2 AA3 2 ALA A 126 LEU A 127 -1 O ALA A 126 N ILE A 14 CISPEP 1 ARG A 55 PRO A 56 0 0.22 CISPEP 2 GLY A 95 GLY A 96 0 -1.79 CRYST1 29.910 67.480 78.650 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.033434 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014819 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012715 0.00000